Search by Drug Name or NDC

    NDC 61919-0880-15 Hydroxyzine Pamoate 25 mg/1 Details

    Hydroxyzine Pamoate 25 mg/1

    Hydroxyzine Pamoate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is HYDROXYZINE PAMOATE.

    Product Information

    NDC 61919-0880
    Product ID 61919-880_f216106d-2255-fc25-e053-2a95a90aeff8
    Associated GPIs 57200040200105
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Hydroxyzine Pamoate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hydroxyzine Pamoate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name HYDROXYZINE PAMOATE
    Labeler Name Direct_Rx
    Pharmaceutical Class Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA087479
    Listing Certified Through 2024-12-31

    Package

    NDC 61919-0880-15 (61919088015)

    NDC Package Code 61919-880-15
    Billing NDC 61919088015
    Package 15 CAPSULE in 1 BOTTLE (61919-880-15)
    Marketing Start Date 2019-06-03
    NDC Exclude Flag N
    Pricing Information N/A